FDA Approved: KOSELUGO — Supplemental Application (AstraZeneca Pharmaceuticals LP)

View source ↗

Summary

FDA approved a supplemental application for KOSELUGO (selumetinib) from AstraZeneca, resulting in updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type
• Plexiform Neurofibroma

Drugs mentioned

• Koselugo (selumetinib)

Snippet

SUPPL AP for KOSELUGO (SELUMETINIB)